DE3200763A1 - Arzneimittel-formkoerper - Google Patents

Arzneimittel-formkoerper

Info

Publication number
DE3200763A1
DE3200763A1 DE19823200763 DE3200763A DE3200763A1 DE 3200763 A1 DE3200763 A1 DE 3200763A1 DE 19823200763 DE19823200763 DE 19823200763 DE 3200763 A DE3200763 A DE 3200763A DE 3200763 A1 DE3200763 A1 DE 3200763A1
Authority
DE
Germany
Prior art keywords
medicament
living body
acid
molded body
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19823200763
Other languages
German (de)
English (en)
Other versions
DE3200763C2 (enrdf_load_stackoverflow
Inventor
Masami Hiratsuka Kanagawa Asakura
Takashi Kanazawa Ishikawa Iwa
Katsuya Yokohama Kanagawa Sakai
Hiroshi Oomuta Fukuoka Takayanagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP273781A external-priority patent/JPS57116008A/ja
Priority claimed from JP16199881A external-priority patent/JPS5865211A/ja
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Publication of DE3200763A1 publication Critical patent/DE3200763A1/de
Application granted granted Critical
Publication of DE3200763C2 publication Critical patent/DE3200763C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19823200763 1981-01-13 1982-01-13 Arzneimittel-formkoerper Granted DE3200763A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP273781A JPS57116008A (en) 1981-01-13 1981-01-13 Novel formed drug
JP16199881A JPS5865211A (ja) 1981-10-13 1981-10-13 徐放性成形制ガン剤

Publications (2)

Publication Number Publication Date
DE3200763A1 true DE3200763A1 (de) 1982-11-25
DE3200763C2 DE3200763C2 (enrdf_load_stackoverflow) 1993-02-25

Family

ID=26336200

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19823200763 Granted DE3200763A1 (de) 1981-01-13 1982-01-13 Arzneimittel-formkoerper

Country Status (4)

Country Link
CH (1) CH650405A5 (enrdf_load_stackoverflow)
DE (1) DE3200763A1 (enrdf_load_stackoverflow)
FR (1) FR2497661B1 (enrdf_load_stackoverflow)
GB (1) GB2091554B (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102020203106A1 (de) 2020-03-11 2021-09-16 Lts Lohmann Therapie-Systeme Ag Wirkstoffstempel mit einem Insert zur schlagartigen Applikation

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
DE3484951D1 (de) * 1983-10-14 1991-09-26 Sumitomo Pharma Verlaengerte praeparate mit verzoegerter abgabe.
EP0166315B1 (de) * 1984-06-19 1989-08-23 BASF Aktiengesellschaft Magensaftresistent überzogene zylindrische Pankreatin-Mikrotabletten
DE3688188T2 (de) * 1985-12-27 1993-10-14 Koken Kk Verfahren zur Herstellung einer Formulierung mit verzögerter Freisetzung.
JPS63503540A (ja) * 1986-05-29 1988-12-22 フセソユーズヌイ、ナウチノ‐イスレドワーチェルスキー、イ、イスピタテルヌイ、インスチツート、メディツィンスコイ、チェフニキ 生物分解性ポリマー製の抗腫瘍性フィルム
AU606383B2 (en) * 1987-03-06 1991-02-07 Research Triangle Institute Polymer blends for selective biodegradability
DE69101291T2 (de) * 1990-08-30 1994-07-07 Senju Pharma Co Zusammensetzung zur kontrollierten Abgabe von Medikamenten.
FR2673843B1 (fr) * 1991-03-14 1995-01-13 Centre Nat Rech Scient Composition pharmaceutique implantable, bioresorbable a base de poly(acide lactique), destinee a mettre en óoeuvre une antibiotherapie interne locale.
GB2281709B (en) * 1993-09-14 1998-04-08 Fujitsu Ltd Biodegradable resin moulded article
US5542920A (en) * 1994-09-12 1996-08-06 Delab Needle-less parenteral introduction device
US5595973A (en) 1994-09-12 1997-01-21 Biomeasure Incorporated Protection of hemopoietic cells during chemotherapy or radiotherapy
AU745055B2 (en) * 1994-09-12 2002-03-07 Delab Parenterally administered medicament
AU3634595A (en) * 1994-09-16 1996-03-29 Angus Chemical Company Bis-oxazolidines and their use
FR2756493B1 (fr) * 1996-12-02 2001-04-13 Delab Dispositif d'administration locale de formulations solides ou semi-solides
US20020111603A1 (en) 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
US6485514B1 (en) * 1997-12-12 2002-11-26 Supergen, Inc. Local delivery of therapeutic agents
FR2770134B1 (fr) * 1998-10-28 2002-06-07 Delab Formulations solides ou semi-solides pour administration locale
JP2002542183A (ja) 1999-04-16 2002-12-10 ノボ ノルディスク アクティーゼルスカブ 成形可能な乾燥した医薬製剤
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
AU2014253541B2 (en) * 2007-02-22 2016-07-28 Glide Pharmaceutical Technologies Limited Solid pharmaceutical and vaccine dose
GB2446780A (en) 2007-02-22 2008-08-27 Glide Pharmaceutical Technolog An elongate parenteral injection body having an injection point of angle 10 to 40 degrees.
ES2362525B8 (es) * 2009-10-08 2013-01-03 Azurebio, S.L. Formulación de medicamentos en forma de agujas percutaneas penetrantes.
US10596330B2 (en) 2015-08-26 2020-03-24 Medtronic Xomed, Inc. Resorbable, drug-eluting submucosal turbinate implant device and method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2051580A1 (de) * 1969-10-23 1971-05-06 E I Du Pont de Nemours and Co, Wilmington, Del (V St A ) Polylactid Arzneimittel Mischungen
US3887699A (en) * 1969-03-24 1975-06-03 Seymour Yolles Biodegradable polymeric article for dispensing drugs
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857932A (en) * 1970-09-09 1974-12-31 F Gould Dry hydrophilic acrylate or methacrylate polymer prolonged release drug implants
US4014987A (en) * 1974-06-04 1977-03-29 Alza Corporation Device for delivery of useful agent
US4249531A (en) * 1979-07-05 1981-02-10 Alza Corporation Bioerodible system for delivering drug manufactured from poly(carboxylic acid)

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887699A (en) * 1969-03-24 1975-06-03 Seymour Yolles Biodegradable polymeric article for dispensing drugs
DE2051580A1 (de) * 1969-10-23 1971-05-06 E I Du Pont de Nemours and Co, Wilmington, Del (V St A ) Polylactid Arzneimittel Mischungen
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GILDING, D.K. et al.: Polymer 20, 1459, 1979 *
MÜLLER, B.W. et al.: Acta Pharmaceutica Technologica, 22, 91, 92, 100, 103, 1976 *
WISE, D.L. et al.: J.Pharm.Pharmacol., 1980, 32, 399-403 *
WISE, D.L. et al.: Midland Macromolecular Monographs (Polym.Deliv.Syst.) 5, 121, 1978 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102020203106A1 (de) 2020-03-11 2021-09-16 Lts Lohmann Therapie-Systeme Ag Wirkstoffstempel mit einem Insert zur schlagartigen Applikation

Also Published As

Publication number Publication date
DE3200763C2 (enrdf_load_stackoverflow) 1993-02-25
FR2497661B1 (fr) 1985-10-18
FR2497661A1 (fr) 1982-07-16
GB2091554A (en) 1982-08-04
CH650405A5 (fr) 1985-07-31
GB2091554B (en) 1984-09-12

Similar Documents

Publication Publication Date Title
DE3200763A1 (de) Arzneimittel-formkoerper
DE69423582T2 (de) Arzneimittelzusammensetzung mit kontrollierter Wirkstoffabgabe
DE60003803T2 (de) Trockene formbare arzneistoffformulierung
DE60111068T2 (de) Polymere verabreichungsform von leuprolid mit verbesserter wirksamkeit
DE3685958T2 (de) Durch ultraschall gesteuerte polymere vorrichtungen zur wirkstoffabgabe.
DE3780862T2 (de) Implantate zur abgabe biologisch aktiver makromolekuele.
DE69224131T2 (de) Polymerzusammensetzungen zur Verwendung als Implantate mit verzögerter Abgabe
DE69030095T2 (de) Vorrichtung zum verabreichen von medikamenten auf schleimhautgewebe
DE69728371T2 (de) Verfahren zur herstellung von implantaten, die leuprolid enthalten
EP0281778A1 (de) Mehrteilige implantierbare Arzneizubereitung mit Langzeitwirkung
DE3131610C2 (enrdf_load_stackoverflow)
EP0428038B1 (de) Transdermale Applikation von 2-Amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
DE69900746T2 (de) Gesteuerte verabreichung von peptiden oder proteinen
DE69826451T2 (de) Anästhetischer Knochenzement
DE69705746T2 (de) Injizierbare depotgelzubereitung und herstellungsverfahren
EP1519713B1 (de) Wirkstofffreisetzungssysteme auf basis von bioabbaubaren oder biokompatiblen polymeren mit formgedaechtniseffekt
DE4031881C2 (de) Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
DE2158226A1 (de) Arzneimittelwirkstofftraeger aus siliconkautschuk
DE3822459A1 (de) Wasserunloesliche polypeptide
DE2224534B2 (de) Pharmazeutisches praeparat mit langsamer wirkstoffabgabe
DE3806562A1 (de) Zweikammerspritze mit einer fuellung aus aktivitaetsempfindlichem humanen protein als wirkstoff
DE2445971A1 (de) Arzneimittelwirkstofftraeger ii
DE1219180B (de) Verfahren zur Herstellung von prothetischen Vorrichtungen und chirurgischem Naehmaterial
DE69227259T2 (de) Film zur lokalen arzneistoffabgabe für periodontale behandlung
DE69013797T2 (de) Gehirnspezifische Zubereitung mit gesteuerter Abgabe.

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8305 Restricted maintenance of patent after opposition
D4 Patent maintained restricted
8327 Change in the person/name/address of the patent owner

Owner name: MITSUI CHEMICALS, INC., TOKIO/TOKYO, JP

8339 Ceased/non-payment of the annual fee